Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon

European Heart Journal

Volumn 30, Issue 7, 2009, Pages 765-772

  Kawai, Yusuke ^a   Hisamatsu, Kenichi ^a   Matsubara, Hiromi ^a   Dan, Kazuhiro ^a   Akagi, Satoshi ^a   Miyaji, Katsumasa ^a   Munemasa, Mitsuru ^a   Fujimoto, Yoshihisa ^a   Kusano, Kengo F ^b   Ohe, Tohru ^b  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Acute coronary syndrome; Nicorandil; Percutaneous coronary intervention; Slow coronary flow phenomenon

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STABLE ANGINA PECTORIS; THROMBOSIS PREVENTION;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-ARRHYTHMIA AGENTS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; NICORANDIL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 64849095094     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp077     Document Type: Article

References (26)

1. Karagounis L, Sorensen SG, Menlove RL, Moreno F, Anderson JL. Does thrombolysis In myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. J Am Coll Cardiol 1992;19:1-10.
2. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, Negora S. Nakatsuchi Y, Taniyama Y, Higashino Y, Fujii K, Minamino T. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty In patients with acute anterior wall myocardial infarction. Circulation 1996;93:1993-1999.
3. Abbo KM, Dooris M, Glazier S, O'Neill WW, Byrd D, Grines CL, Safian RD. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995;75:778-782.
4. Kenner MD, Zajac EJ, Kondos GT, Dave R, Winkelmann JW, Joftus J, Laucevicius A, Kybarskis A, Berukstis E, Urbonas A, Feinstein SB. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995;76:861 -868.
5. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
6. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-662.
7. Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T, Nagata S, Hori M. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002;106: 1672-1677.
8. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murchara T, Matsubara T. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevatlon myocardial infarction. Circulation 2005;112: 1284-1288.
9. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-660.
10. Sakata Y, Kodama K, Komamura K, Lim YJ, Ishikura F, Hirayama A, Kitakaze M, Masuyama T, Hori M. Salutaty effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J 1997;133:616-621.
11. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51(Suppl. 4):5-40.
12. Gibson CM, Cannon CP, Daley WL Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count a quantitative method of assessing coronary artery flow. Circulation 1996;93: 879-888.
13. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99: 2720-2732.
14. Sato H, Iida H, Tanaka A, Tanaka H, Shimodouzono S, Uchida E, Kawarabayashi T, Yoshikawa J. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow In acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. J Am Coll Cardiol 2004;44:300-304.
15. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Bairn DS. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994;89:2514- 2518.
16. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, Nishikawa N, Higashino Y, Fujii K, Minamino T. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-1199.
17. Taylor AJ. Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Gross M, Diets R, Friedrich MG. Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J 2006;151:891.e1-891.e7.
18. Korosoglou G, Geiger B, Hansen A, Hardt SA, Giannitsis E, Selter C, Katus HA, Kuecherer H. Usefulness of real-time myocardial perfusion imaging to evaluate alterations of myocardial blood flow in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Am J Cardiol 2005;96: 885-891.
19. Lim SY, Bae EH, Jeong MH, Kang DG, Lee YS, Kim KH, Lee SH, Yoon KH, Hong SN, Park HW, Hong YJ, Kim JH, Kim W, Ahn YK. Cho JG, Park JC, Kang JC. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention. Circ J 2004;68:928-932.
20. Matsuo H, Watanabe S, Segawa T, Yasuda S, Hirose T, Iwama M, Tanaka S, Yamakl T, Matsuno Y, Tomita M, Minatoguchi S, Fujiwara H. Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensltive K+ channel opener nicorandil. Eur Heart J 2003;24:1296-1303.
21. Okamura A, Rakugi H, Ohishi M, Yanagitani Y, Shimizu M, Nishii T, Taniyama Y, Asai T, Takiuchi S, Moriguchi K, Ohkuro M, Komai N, Yamada K, Inamoto N, Otsuka A, Higaki J, Ogihara T. Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin. J Am Coll Cardiol 2001; 37:719-725.
22. Ishii H, lchimiya S, Kanashiro M, Amano T, Matsubara T, Murohara T. Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia. Diabetes care 2006;29:202-206.
23. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kirnura K, Fujii K, Ishihara M, Salto Y, Tomoike H, Kitamura S. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial Infarction (J-WIND): two randomised trials. Lancet 2007;370:1483-1493.
24. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antonlucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005;293:1063- 1072.
25. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, YoshikawaJ, Becker AE. Neutrophil Infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106:2894-2900.
26. Mizumura T, Nithipatikom K, Gross GJ, Bimakallm, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function In dogs. Circulation 1995;92:1236-1245.